Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03455322|
Recruitment Status : Unknown
Verified January 2018 by Eman Desoki, National Hepatology & Tropical Medicine Research Institute.
Recruitment status was: Recruiting
First Posted : March 6, 2018
Last Update Posted : March 8, 2018
National Hepatology & Tropical Medicine Research Institute
Information provided by (Responsible Party):
Eman Desoki, National Hepatology & Tropical Medicine Research Institute
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 15, 2018|